Study Completed

Contraception

Bayer Identifier:

Trial_305043

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Comparison to investigate the influence of Yasmin® vs Microgynon 30® on various parameters associated with well-being in healthy female subjects

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Female

Age

16 - 40 Years

Trial summary

Enrollment Goal

424

Trial Dates

May 2001 - June 2002

Phase

Phase 4

Could I Receive a placebo

N/A

Products

Yasmin (EE30/DRSP, BAY86-5131)

Accepts Healthy Volunteer

N/A

Trial design

Multicenter, single-blind, randomized, parallel-group comparison to investigate the influence of Yasmin® (SH T 470 FA: 30μg ethinylestradiol, 3mg drospirenone) vs Microgynon 30® (SH 7.1155 A: 30μg ethinylestradiol, 150μg levonorgestrel) on various parameters associated with well-being for 7 cycles in healthy female subjects

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A